Locations:
Search IconSearch

Gynecologic Oncology

Cervical cancer cells

Fertility-Sparing Management of Early-Stage Cervical Cancer

Studying trends of conization with lymph node evaluation, trachelectomy and radical hysterectomy

BRCA1
February 28, 2023/Cancer

Optimizing Care for Those With Genetic Predisposition to Ovarian and Breast Cancer

A well-prepared team meets the distinctive needs of patients at hereditary high risk

Ovarian tumor
January 23, 2023/Cancer

Research Shows Link Between Antibiotic Use and Ovarian Cancer Outcomes

Reassessing antibiotic dosage and type and restoring gut biome could improve survival rates

HIPEC

Could HIPEC Hold Promise for Advanced Endometrial Cancer?

Study showed that regimen was well-tolerated in cohort with aggressive carcinoma

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Endometriosis

New Risk Model Can Help Guide Clinical Care for Endometrioid Endometrial Cancer

Research helps identify patients who might benefit from adjuvant therapies

Ovarian tumor

PARP Inhibitors Decrease Response to Subsequent Platinum-Based Chemotherapy in Recurrent Ovarian Cancer

Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer

Fecal incontinence pessary

Vaginal Insert Offers Relief from Fecal Incontinence

Device provides alternative to conservative management and surgical procedures

Illustration of endometrial cancer
March 4, 2021/Cancer

Primary Cytoreductive Surgery Improves Survival Significantly Compared with Other Types of Treatment

A new study explores survival outcomes based on treatment modality

BackPage 2 of 3Next

Advertisement

Ad